Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASB Treat study of nitrofurantoin for asymptomatic bacteriuria in pregnancy
2011-000129-61Phase 3Active
- Sponsor
- AMC Health
- Start
- Oct 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nitrofurantoin in asymptomatic bacteriuria (ASB), pyelonephritis and preterm birth (2 arms), sponsored by AMC Health. Primary endpoint: Composite of pyelonephritis and delivery before 34 weeks. Started Oct 2011; status: active.
02
Drugs
nitrofurantoin
03
Conditions
asymptomatic bacteriuria (ASB)pyelonephritispreterm birth
Beyond the preview
Go deeper on 2011-000129-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000129-61.